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In worldwide conditions of increasingly antibiotic-resistant hospital infections, it is important to 
research alternative therapies. Bdellovibrio bacteriovorus bacteria naturally prey on Gram-negative 
pathogens, including antibiotic-resistant strains and so B. bacteriovorus have been proposed as “living 
antibiotics” to combat antimicrobially-resistant pathogens. Predator-prey interactions are complex and 
can be altered by environmental components. To be effective B. bacteriovorus predation needs to work 
in human body fluids such as serum where predation dynamics may differ to that studied in laboratory 
media. Here we combine mathematical modelling and lab experimentation to investigate the predation 
of an important carbapenem-resistant human pathogen, Klebsiella pneumoniae, by B. bacteriovorus 
in human serum versus buffer. We show experimentally that B. bacteriovorus is able to reduce prey 
numbers in each environment, on different timescales. Our mathematical model captures the 
underlying dynamics of the experimentation, including an initial predation-delay at the predator-prey-
serum interface. Our research shows differences between predation in buffer and serum and highlights 
both the potential and limitations of B. bacteriovorus acting therapeutically against K. pneumoniae in 
serum, informing future research into the medicinal behaviours and dosing of this living antibacterial.
Infections caused by antibiotic-resistant Gram-negative bacteria have steadily risen over the past decade and pose 
a serious risk to public health. This is illustrated by the fact that Gram-negative bacteria are currently responsible 
for more than 30% of all hospital-acquired infections1 and are associated with high levels of morbidity and mor-
tality in the Intensive Care Unit setting2–5. Consequently, new therapies effective against drug resistant isolates are 
urgently needed. One option mooted is the use of predatory bacteria, such as Bdellovibrio bacteriovorus, as thera-
peutic agents6, 7. B. bacteriovorus HD100 is a small (0.3 µm × 1 µm) Gram-negative bacterium that preys on other 
Gram-negative bacteria as part of its developmental lifecycle, which has a number of well-defined stages in liquid 
conditions8. During this lifecycle, the prey act as both food source and housing for the predator9. Firstly, highly 
motile attack phase predator- cells are propelled by a single flagellum until they encounter a prey cell, at which 
point they attach to the outer membrane and invade the prey periplasm, forming a predator+dead-prey structure 
called a bdelloplast. Once established within the periplasm, B. bacteriovorus begin filamentous replication by vir-
tue of sequestration of prey cell nutrients. Depending on the prey and external environment, the typical lifecycle 
of B. bacteriovorus lasts 3–4 hours and when complete results in lysis of the prey and release of new predatory 
progeny. The number of predators released is dependent on the size of the prey cell10.
Understanding the dynamics of B. bacteriovorus predation under the in vivo conditions found in a treatment 
setting, is critical to developing this predatory bacterium as a “living antibiotic”. Formulating a dosage regime for any 
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future administration of a living organism inside a complex system, such as the human body, requires a comprehen-
sive understanding of the factors affecting predation. Previously published in vitro predation studies in buffer and 
bacteriological media have been informative7, 11 but need expanding towards physiologically relevant conditions. In 
order to address this issue, we employ an interdisciplinary approach to investigate experimentally and mathemat-
ically model the predation by B. bacteriovorus HD100 of an antibiotic-resistant, carbapenemase producing (KPC) 
clinical isolate of Klebsiella pneumoniae in whole human serum at 37 °C; conditions that better represent those found 
in vivo. K. pneumoniae KPC is an important human pathogen and member of the ESKAPE group12 of antibiotic 
resistant human pathogens with carbapenem resistance, which further limits the treatment options for patients. It is 
a major cause of nosocomial infections globally and has an associated high mortality rate13.
Early mathematical modelling of B. bacteriovorus predation, in buffers/simple lab media alone, includes 
the influential work of Varon and Zeigler14 who used a Lotka-Volterra model15, 16 to investigate predation on 
a Photobacterium species. Experimentally they used low concentrations of both predator and prey in a tri-salt 
buffer to determine the concentrations necessary for survival of B. bacteriovorus and to induce oscillatory 
waves of predatory behaviour in prey populations. They then used this data to estimate parameters for their 
Lotka-Volterra model, which predicted that “the prey density required to give bdellovibrios a 50% chance of sur-
vival was calculated to be at least 3.0 × 106 cells per ml”, although this has been later disputed17. In contrast, driven 
by the potential therapeutic application, our model focuses on prey elimination rather than B. bacteriovorus 
survival. We take the Lotka-Volterra model as a basis for our model, but adapt it significantly to reflect the unique 
predation mechanism of B. bacteriovorus. Most significantly, our model allows us to capture temporal aspects 
of predation not accounted for in Varon and Zeiglers’ model, and also assess the impact of prey resistance and 
environmental variables on predation outcome.
Other early work includes a model of B. bacteriovorus predation on Escherichia coli which explicitly includes 
a bdelloplast stage with an incubation period during which the predator B. bacteriovorus grows and replicates 
inside prey18. In contrast to our model, this model only considered predation in buffer with no consideration of 
immune system effects, and only looked at short time scales (<10 hours after inoculation), allowing the authors to 
use a much simpler model than the one we present. We also note that the parameter estimates reported for prog-
eny number (from E. coli) are larger than those that have since been observed experimentally. Later modelling 
work by Wilkinson19 and Hobley20 examined predation in the presence of a third ‘decoy’ species, either inert or 
live. These studies are an important step away from the previous tightly controlled two species model systems, and 
the presence of other bacterial species is important in assessing the clinical application of B. bacteriovorus against 
mixed bacterial infections. These studies, however, unlike the model presented in this work, consider predation 
in buffer rather than in a complex growth environment as would be the case in any future clinical application.
Most recently, Dattner21 modelled B. bacteriovorus predation in a habitat of sand suspended in buffer. The 
authors proposed an alternative approach to the standard (numerical integration based) parameter estimation 
approach used in analysis of non-linear dynamics. By taking a simplified ‘strategic’ model rather than a mecha-
nistic, model the authors were able to use a statistical direct integral approach to estimate the model parameters 
and produced a fit to a small sample of experimental data points. Whilst this approach may give insights into 
predation dynamics in an artificially simplified experimental environment, it is unlikely to be suitable for the 
more complex environment that would be present in the clinical application of B. bacteriovorus, such as serum. 
In a whole human environment, several immunological and/or antimicrobial factors (such as antibodies, anti-
microbial peptides and leukocytes) will act upon the predatory bacteria, potentially killing the predators before 
predation can occur. These factors are complex but important to understand and quantify as they will impact 
efficacy of B. bacteriovorus used as a therapeutic.
In this study, we used standard numerical integration to estimate the model parameters and simulate time 
course behaviour in human serum at the physiological temperature of 37 °C. This results in a complex parame-
terisation of the predation process, even for serum (albeit without the leukocytes that would be present in whole 
blood, an area that requires significant further experimentation). By capturing the mechanistic complexity of the 
experimental system, we are able to use our model to guide the design of experiments and to suggest mechanisms 
to further investigate. Furthermore, our model allows rapid prediction of predation outcomes over longer times-
cales, which would be difficult and labour-intensive to obtain experimentally.
Mathematical modelling of B. bacteriovorus predation cannot be thought of as a variation of more traditional 
animal predator-prey dynamics22, 23. The B. bacteriovorus intra-prey, life cycle length and uniformity leads to a 
synchronicity of prey bursting and replicated progeny-predator release, in controlled laboratory media (such 
as buffer), and when an almost equal number of predators to prey are present at the start of predation. Whilst 
this will not affect the long term (relative to life cycle length) dynamics of the model, it has a significant impact 
on the shorter term dynamics (less than the cycle length). Previous modelling work for predation in buffer14 
did not include the impact that synchronous prey-bursting may have on the validity of the model at early time 
points, and the early mathematical models were not able to fully account for the differences between bacterial 
and animal predation. In this paper, we present a more clinically applicable ordinary differential equation (ODE) 
population-based model of bacterial predator-prey dynamics which is experimentally validated and informs 
upon both short- and long-term dynamics in buffer and human serum. We also consider some important aspects 
of predation that as yet have not been fully investigated. Firstly we consider the baseline conditions of predation 
in buffer, over longer time scales (up to 96 hours). This allows modelling of the prey outgrowing their predators, 
linking to reports from previous experimental work14, 17. Secondly, we mathematically model and experimentally 
determine the dynamics of B. bacteriovorus predation of K. pneumoniae in human serum; not the usual buffer 
employed for most previous predation studies. We quantify and demonstrate that pathogen predation in human 
serum does occur under certain conditions, that the dynamics of predation in serum is markedly different to that 
in buffer and that there is serum to serum variation.
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A more complete understanding of the potential and limitations of predation in human serum is essential 
if ultimately B. bacteriovorus is to be considered for use as a living antibiotic. Both our experimental work and 
model show a pattern of delayed predation in serum initially lowering the K. pneumoniae load, but this is followed 
by prey regrowth, which will need to be fully understood in future work if we and other Bdellovibrio researchers 
are to prevent re-infection. The interdisciplinary approach we take here is crucial to achieving that aim, with the 
experimental work highlighting the marked differences between predation in serum and buffer, and the mathe-
matical modelling providing insight into potential reasons for these differences. This paper takes important steps 
towards increasing our understanding of B. bacteriovorus predation in a realistic environment and provides a 
framework for further developing B. bacteriovorus as a potential therapeutic.
Methods
Bacterial strains, serum, media and growth conditions. Klebsiella pneumoniae EARSSU271 is a car-
bapenemase producing (KPC) clinical isolate and was provided via Dr Mathew Diggle (EMPATH Nottingham 
University Hospitals UK). K. pneumoniae was cultured on LB agar and YT broth at 37 °C. B. bacteriovorus 
HD10024 was cultured as described previously25. Briefly, B. bacteriovorus stocks were prepared by culture on 
stationary phase E. coli S17-126 prey suspended in Ca/HEPES buffer (5.49 g/l HEPES free acid, 0.284 g/l calcium 
chloride dehydrate, pH 7.6). Predatory cultures were prepared by culturing of E. coli S17-1 in YT broth (5 g/l 
sodium chloride, 5 g/l peptone, 8 g/l tryptone, pH 7.5) at 37 °C with shaking for approximately 16 h. Stationary 
phase prey cells (3 ml) were then added to 1 ml of a previous B. bacteriovorus predatory culture in 50 ml Ca/
HEPES buffer and incubated at 29 °C for at least 16 h until the culture had cleared. (Predator and prey cell num-
bers were enumerated from cultures as described in experimentation below). Human serum (pooled from male 
AB plasma) was sourced from Sigma (H4522, Sigma-Aldrich Corporation, St. Louis, MO, USA).
Assaying reduction of K. pneumoniae numbers by human serum alone. K. pneumoniae was cul-
tured in YT broth (20 ml) at 37 °C with shaking (200 rpm) for approximately 16 h. K. pneumoniae was pelleted by 
centrifugation (5,500 × g, 10 min, 29 °C) and resuspended to an optical density (OD600 nm) of 2.0 in whole human 
serum (Sigma H4522, Sigma-Aldrich Corporation, St. Louis, MO, USA). The suspension was serially diluted 1:10 
with fresh human serum in a total volume of 3 ml. Serially diluted cultures were incubated at 37 °C with shaking 
(200 rpm) and cell numbers were enumerated periodically by the method of Miles and Misra27 on LB agar in trip-
licate with three biological repeats. This was done to assay for any cell number reduction by serum alone.
Assaying reduction of B. bacteriovorus HD100 numbers by human serum alone. B. bacterio-
vorus predatory cultures (500 ml) prepared as described previously were passed through a 0.45 µm Millex filter 
(Millipore, Billerica, MA, USA) to remove any remaining starter-prey, E. coli S17-1. The filtered predatory culture 
was centrifuged (5,500 × g, 20 min, 29 °C) to pellet cells. The pellet was resuspended in 500 µl Ca/HEPES to give 
a 1000 × concentrated suspension typically containing approximately 4 × 1010 pfu/ml of B. bacteriovorus. The 
suspension was serially diluted 1:10 with Ca/HEPES buffer in a total volume of 500 µl. Serially diluted B. bacteri-
ovorus suspension (450 µl) was added to 4.45 ml of whole human serum and suspensions were incubated at 37 °C 
with shaking (200 rpm). Cell numbers were determined periodically by serial dilution and enumeration of B. bac-
teriovorus plaques in a soft YPSC overlay agar (0.25 g/l magnesium sulphate, 0.5 g/l sodium acetate, 1.0 g/l Bacto 
peptone, 1.0 g/l yeast extract, pH 7.6; adjust to 0.25 g/l anhydrous calcium chloride after autoclaving). For YPSC 
bottom agar, add 10 g/l agar. For YPSC overlay agar, add 6 g/l agar) containing a lawn of E. coli S17-1 as described 
previously25. Enumerations were performed in duplicate (two technical repeats) with two biological repeats.
Predation assays in buffer and serum. Predatory cultures of B. bacteriovorus (50 ml) prepared as 
described earlier in methods were passed through a 0.45 µm Millex filter to remove any remaining E. coli S17-1 
and the filtered predatory culture was centrifuged at 5,500 × g, 20 min, 29 °C. The pellet was resuspended in 1 ml 
of Ca/HEPES to give a 50 × concentrated preparation typically containing approximately 5 × 109 cfu/ml of pred-
atory B. bacteriovorus. K. pneumoniae prey was cultured in YT broth (20 ml) at 37 °C with shaking (200 rpm) for 
approximately 16 h. Prey cells were pelleted by centrifugation (5,500 × g, 10 min, 29 °C) and resuspended to an 
optical density (OD 600 nm) of 1.0 (equivalent to approximately 5 × 109 cfu/ml) in 5 ml whole human serum (Sigma 
H4522, Sigma-Aldrich Corporation, St. Louis, MO, USA) or 5 ml Ca/HEPES buffer. Predation assays were started 
by combining 5 ml of prey suspension with 500 µl of concentrated B. bacteriovorus suspension or 500 µl of Ca/
HEPES as a control in a sterile Falcon tube (50 ml) and incubated at 37 °C in a rotary shaker (200 rpm). Starting 
predator and prey numbers were determined by enumeration of both prey and predator populations. Changes in 
prey population were enumerated by method of Miles and Misra plating in triplicate. Changes in predator popu-
lation were determined by serial dilution and enumeration of B. bacteriovorus plaques in a soft YPSC overlay agar.
Fluorescence microscopy. For fluorescence microscopy, predation assays in serum or buffer were prepared 
as described in methods. To be able to visualise small predators in the visually challenging serum environment, 
we used B. bacteriovorus HD100 expressing, constitutively from the chromosome, Bd0064mCherry fluorescent 
protein (named HD100 mCherry) described in Willis et al.28. Aliquots (10 µl) of predation assay were withdrawn 
for microscopy and placed on a solid 1% agarose pad prepared in Ca/HEPES buffer. Fluorescent microscopic 
images were acquired using a Nikon Ti-E Eclipse inverted microscope (excitation 555 nm / emission 640 nm, 1 s 
exposure).
Analysis of B. bacteriovorus morphology in serum. MicrobeJ image analysis software29 was used to 
detect fluorescent B. bacteriovorus HD100 mCherry cells and measure the roundness (4 × area / (π × major 
axis2) of each individual cell. A roundness cut off of 0.65 was selected to distinguish between cells with typical 
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B. bacteriovorus vibroid morphology (roundness score < 0.65) and those with an abnormal round morphology 
(roundness score ≥ 0.65). Manual inspection of cells near the cutoff validated that the cells were correctly called.
Analysis of K. pneumoniae cell area in serum. MicrobeJ image analysis software was used to detect K. 
pneumoniae prey cells in serum and measure the area of each individual cell. The mean cell area of the K. pneu-
moniae KPC population in serum was determined at 0 hours (n = 271 individual measurements) and 96 hours 
(n = 170 individual measurements).
Pre-exposure of predator and prey to serum followed by predation in buffer. To test whether 
delay effects seen in predation in serum were due predominately to serum-induced changes in predator or prey, 
additional experiments were performed. B. bacteriovorus predatory cultures (50 ml, typically containing approx-
imately 1 × 108 pfu/ml) prepared as described were passed through a 0.45 µm Millex filter to remove any remain-
ing E. coli S17-1 and the filtered predatory culture was centrifuged at 5,500 × g, 20 min, 29 °C. The pellet was 
resuspended in 5 ml of whole human serum and incubated at 37 °C with shaking (200 rpm) for 2 h. K. pneumoniae 
prey was cultured in YT broth (20 ml) at 37 °C with shaking (200 rpm) for approximately 16 h. Prey cells were pel-
leted by centrifugation (5,500 × g, 10 min, 29 °C) and resuspended to an optical density (OD 600 nm) of 1.0 (equiva-
lent to approximately 5 × 109 cfu/ml) in 5 ml whole human serum and incubated at 37 °C with shaking (200 rpm) 
for 2 h. Following exposure to serum, predator and prey suspensions were pelleted by centrifugation (5,500 × g, 
10 min, 29 °C). K. pneumoniae pellets were resuspended in 5 ml of Ca/HEPES and B. bacteriovorus HD100 pellets 
were resuspended in 500 µl of Ca/HEPES. To begin predation assays, 500 µl of B. bacteriovorus suspension was 
added to 5 ml of K. pneumoniae KPC suspension in Ca/HEPES and incubated at 37 °C with shaking (200 rpm). 
Predation was determined by enumeration of both prey and predator populations as described. Experiments 
were performed with three biological repeats. Prey enumerations were performed with technical triplicates and 
predator enumerations performed with technical duplicates.
Measure of complement activity during predation. To establish how complement levels changed dur-
ing predation in serum, haemolysis assays were carried out using standard protocols as described earlier with 
minor modifications30, 31. Predation assays with B. bacteriovorus (approximate starting concentration 1 × 108 cfu/
ml) and K. pneumoniae (approximate starting concentration 5 × 109 cfu/ml) in whole human serum were pre-
pared as described previously and incubated at 37 °C with shaking (200 rpm). Aliquots of serum (1 ml) were 
removed at each time point and passed through a 0.2 µM Millex syringe driven filter to remove both predator and 
prey. Aliquots of filtered serum were immediately frozen (−20 °C) prior to determining remaining complement 
activity. The classical complement pathway activity was tested with sheep erythrocytes opsonised with Rabbit 
anti-sheep red blood cell stroma IgG antibodies (Sigma-Aldrich). Sheep erythrocytes were washed twice in 0.9% 
NaCl and twice in GVB++ (3.12 mM barbitone, 0.97 mM sodium barbiturate, 145 mM NaCl, 0.83 mM MgCl2, 
0.25 mM CaCl2 with 0.1% gelatin). The erythrocytes were resuspended in GVB++ to 109 cells/ml and incubated 
with the antibody for 30 minutes at 37 °C, followed by incubation on ice for 45 minutes. The opsonized sheep 
cells (EA) were washed twice in GVB++ and resuspended to 108 cells/ml. The serum samples were serially diluted 
2-fold in 50 µl of GVB++ and incubated with 25 µl of EA at 37 °C for 30 minutes. The assay was stopped by adding 
125 µl of cold GVB++ buffer. The assay controls included 100% lysis control (25 μl of EA lysed in 175 of μl deion-
ized water) and blank (25 μl of EA incubated in 175 μl of GVB++). The samples were centrifuged briefly (5000 x g, 
2 minutes) to pellet intact erythrocytes and the haemolysis was measured spectrophotometrically as the amount 
of released haemoglobin (OD at 415 nm) in a microplate reader.
Determination of B. bacteriovorus HD100 burst size. The average number of predator progeny 
released from K. pneumoniae prey cells following infection and replication was determined by video microscopy 
to aid parameterization. Briefly, K. pneumoniae cells were prepared and infected with B. bacteriovorus HD100 
following the protocol described for predation assays with K. pneumoniae cells resuspended in Ca/HEPES buffer. 
Predation assays were incubated at 37 °C with shaking (200 rpm) for 2 h and 10 µl of the suspension was then 
removed from the assay and placed on a solid 1% agarose pad surface prepared in Ca/HEPES buffer. Microscopic 
images were acquired over several hours at room temperature every 150 s as described previously32. Microscopic 
images were encoded into time-lapse movies and the number of progeny released from individual prey cells 
counted to give the average burst size (Supplementary material, Figure S1).
Mathematical Modelling. We developed mathematical models of K. pneumoniae KPC predation by B. 
bacteriovorus HD100 in both buffer and human serum. The motility of the bacteria and incubation in a rotary 
shaker led to a relatively homogenous environment, hence we used population based ODEs. The models we 
developed consider how the populations of predator and prey bacteria change over time in different environ-
ments. The models were influenced by previous modelling of B. bacteriovorus predation14, 18–20 as well as a model 
of the interaction of bacteria with serum33. The serum model presented here has ten variables (Table 1) and 27 
parameters (Table 2). We use a reduced version of the serum model to simulate predation in buffer, discounting 
the serum specific variables and related parameters. The full model is shown diagrammatically in Fig. 1, with full 
details of the model given in the supplementary materials. Experimental results were used to set initial conditions 
for the model, estimate rate parameters for the mechanisms of predation, and validate the model for serum and 
for buffer (see supplementary materials for a detailed description). All model simulation, parameter fitting and 
analysis were performed in MATLAB34. Combinations of the model variables were used as reporting variables to 
emulate experimental prey and predator enumeration. Individual model variables were also analysed to explore 
predation dynamics that cannot be observed experimentally.
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Results
Predation of K. pneumoniae KPC in defined buffer. Experimentally, predation of K. pneumoniae KPC 
in a buffer environment at 37 °C was found to be highly reproducible (Fig. 2a) and resembled predation results 
reported for other Gram-negative bacteria such as E. coli, Acinetobacter spp. and Shigella spp. in buffer environ-
ments7, 17. Figure 2a shows a rapid reduction in the viability of K. pneumoniae in the presence of B. bacteriovorus 
HD100 with an approximate four log reduction of prey numbers by four hours. Reduction of prey was concom-
itant with an increase in predator numbers which is indicative of predation. These early time point results reflect 
the typical predatory lifescycle reported for B. bacteriovorus in lab strains of E. coli: an initial period of attachment 
and invasion is followed by prey death and filamentous replication of predator within a bdelloplast and lysis of 
the prey after 3–4 hours6. The timing and magnitude of the reduction in prey viability suggest that these initial 
predation events occurred, in buffer, with a high level of synchronicity which was further confirmed by additional 
microscopy (Supplementary Figure S2).
The mathematical model of predation of K. pneumoniae KPC in buffer by B. bacteriovorus HD100 gave 
a good fit to the experimental data (Fig. 2b). The model includes the effect of debris from predation (termed 
“predation-derived waste” model) on predators and prey. We consider that this waste will have two main effects, 
firstly some can be used by the prey for metabolism (WN), leading to growth of the prey cell population and 
secondly, any unused debris will remain in the media (WM) and contribute to the resistant phenotype suggested 
by the experimental data. The model followed the same trends seen experimentally, with an initial drop in prey 
numbers followed by a rapid regrowth within 24 hours. Such rapid regrowth is not reported for laboratory E. 
coli strains in buffer and may indicate proteolysis of predator by prey, liberating amino-acids for prey nutrition. 
The parameter estimation predicts an internalisation time of 11.5 minutes (k2 in mins) and a replicated predator 
exit time of 4 hours (k3 in hours) in K. pneumoniae, which are broadly in line with published times for E. coli35, 
although species and strain specific variation is to be expected. In addition to predator and prey counts which 
can be measured experimentally, the model allows the examination of other quantities, such as bdelloplast num-
bers and total serum antimicrobial activity, which are difficult to measure quantitatively in vitro, allowing the 
underlying dynamics to be investigated further. The model, with best-fit parameters, predicts that in buffer, B. 
bacteriovorus concentration increases at early time points (up to approximately 8 hours), then declines slowly over 
time at a rate that matches the experimental data and is in line with previous studies14. Figure 2c shows predators 
attached to prey (PBDO), prey with predators inside (PBDI) and transiently attached predators (BDI) over time 
and declining PBDI and PBDO concentrations show that new predation is halted after the first 5 hours, in buffer, 
indicating that all the K. pneumoniae prey bacteria that have not been invaded by a predator are now resist-
ant in the buffer model. The results from both the model and experimental work follow a very similar trend to 
experimental results for in-buffer predation of a different bacterium Erwina caratovora ssp. caratovora presented 
in Shemesh and Jurkevitch17, which show the same pattern of a large drop in prey numbers due to predation 
followed by an apparently resistant regrowth. Our model here supports their conclusions that plastic resistance 
induced by means of environmental changes could explain the experimental results and suggests that the amount 
of resistance is dependent upon the build-up of debris from successful predation.
To test the robustness of the model we conducted a sensitivity analysis at several key time points representing 
different stages of the simulation for the buffer model. Figure 3 shows a one-at-a-time sensitivity analysis for a 
10% change in parameter values at 2, 6 and 24 hours, calculated as described in the supplemental material. This 
showed that the model is largely robust to 10% variations in parameter values. In the short term, the model is 
sensitive to small changes in ρ, k3 and P0, but the longer term dynamics are not affected. Variation in the natural 
death rate of predators, λ, has a long term effect on the B. bacteriovorus concentration. It should also be noted 
that while the system is sensitive to these parameters, they are not all directly amenable to manipulation in an 
experimental setting.
In the first 6 hours of the simulation, K. pneumoniae concentration in the buffer model is sensitive to preda-
tion related parameters (ρ, k3 and starting concentrations) but in the longer term, the model is not sensitive to 
these parameters. This can be explained by longer-term prey regrowth, shown experimentally in Fig. 2a. The 10% 
variation in these parameters changes the temporal dynamics of predation but the total amount of predation 
remains constant. We also looked at both large and smaller parameter changes and found the results to be the 
same (results not shown). Longer term (24 hours), the K. pneumoniae concentration is sensitive only to changes in 
Variable Definition
BDF Free predator
PS Free susceptible pathogen
PR Free resistant pathogen
PBDO Pathogen with predator (outside)
PBDI Pathogen with predator (inside)
BDI Inactivated predator
WN Nutritious predation-derived waste
WM Non-degradable predation-derived waste
I Serum antimicrobials*
R Serum growth resources*
Table 1. Model variables and definitions for both the buffer and human serum predation models. The variables 
marked with *are present in the serum model only.
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the efficiency of metabolism of predation-derived waste (EW). This clearly demonstrates that in the closed exper-
imental system it is the regrowth of K. pneumoniae that dominates experimental outcome. This occurs as a result 
of changing conditions over the course of the experiment, often neglected in previous work. Whilst the amount of 
prey-derived waste present (but not the efficiency of its usage) could possibly be manipulated experimentally in 
vitro, it cannot be altered in vivo, the host-relevant state, so we did not consider that further.
The sensitivity analysis highlights an important concept. Whilst we, and others previously, report on predation 
and factors affecting the amount and rate of predation, the closed batch experimental model may give predation 
dynamics that differ to what might be seen in a medically relevant circulation- perfused, physiological situation. 
However, no such quantitative perfused studies exist in vivo yet, as they are very experimentally challenging. 
Considering the dynamics of serum-based predation in batch is a crucial stepping stone to such future work.
Reduction of predator cell numbers in whole human serum alone. To better understand the effect 
of human serum on the reduction of B. bacteriovorus HD100 and K. pneumoniae and to define parameters for 
our mathematical model, we separately determined the viability of B. bacteriovorus HD100 and K. pneumoniae 
in a serum environment over a range of starting concentrations. Reduction of B. bacteriovorus in human serum 
was strongly dependent on the initial bacterial concentration (Fig. 4a). An initial B. bacteriovorus concentration 
of 3.67 × 107 pfu/ml was found to be cleared from human serum within 24 h. In contrast, B. bacteriovorus was 
found to persist up to 72 h in serum when present at a 100-fold higher initial concentration of 3.17 × 109 pfu/ml. 
To further investigate these dynamics, we developed a model of B. bacteriovorus survival. In order to obtain the 
concentration-dependent behaviour seen in the experimental results we made the B. bacteriovorus degradation 
rate proportional to time, serum antimicrobials and increasing dead B. bacteriovorus cell debris in the serum 
(This is not needed in the buffer model where B. bacteriovorus is not lysed by serum antimicrobials). The serum 
model gives a very early (1 hour) fall in B. bacteriovorus concentration over time that follows the same trends 
as the experimental data (Fig. 4a) for all starting concentrations we considered (Fig. 4c). In the model, initial 
removal of B. bacteriovorus is due to serum antimicrobials, and the model predicts that these are exhausted 
within the first hour of the simulation in the closed batch. However, reduction in B. bacteriovorus continues 
experimentally, (Fig. 4a), past 1 hour, over and above the natural death rate (λ). Removal of B. bacteriovorus at 
these times, in the model, is due to the effect of deleterious products released into the serum from the damaged 
predators. We hypothesise these products may include hydrolytic predatory enzymes detached from their usual 
Parameter Definition Units
k1early Early predator-pathogen binding rate ml cell−1 s−1
k1late Late predator-pathogen binding rate ml cell−1 s−1
k2 Predator internalization rate s−1
k3 Predator reproduction rate (time from entry to exit) s−1
k4 Transient predator-pathogen binding rate s−1
Vmax Maximum pathogen growth rate on serum s−1
Vmax
w Maximum pathogen growth rate on predation-derived waste s−1
E Efficiency of serum resource metabolism arb. units
Ew Efficiency of predation-derived waste resource metabolism arb. units
s Serum growth resource at half maximal growth arb. units
sw Waste growth resource at half maximal growth arb. units
dP Rate of accumulation of predation-derived waste s−1
dBD Debris produced from predator cell death s−1
dI Natural antimicrobial inactivation rate s−1
dmax
BD Maximal predator removal rate due to dead predator debris s−1
dmin
BD Baseline predator removal rate due to dead predator debris s−1
h Rate of change of predator removal rate arb. units
aBD Predator removal rate by antimicrobials s−1
aP Prey removal rate by antimicrobials s−1
cBD Predator dependant antimicrobial inactivation rate s−1
cP Pathogen dependant antimicrobial inactivation rate s−1
f Rate of prey transition to resistance s−1
n Fractional index of pathogen-antimicrobial interaction dimensionless
ρ Predator progeny number dimensionless
λ Natural predator death rate s−1
ν Proportion of viable invaded prey dimensionless
δ Reduced attachment length at early timepoints h−1
I0 Initial serum antimicrobial concentration arb. units
R0 Initial serum growth resource concentration arb. units
Table 2. Parameters used in both buffer and serum models with definitions and units.
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internal predator self-protection proteins36. We also considered a simpler model for B. bacteriovorus reduction, 
with no antimicrobial-independent degradation. Whilst this gave a good fit to experimental data at a low initial 
concentration (3.67 × 107 pfu/ml), it was not able to account for B. bacteriovorus reduction at higher initial con-
centrations ( > 3.67 × 107 pfu/ml).
Reduction of prey cell numbers in whole human serum alone. The survival of K. pneumoniae prey 
in human serum was similarly investigated over a range of starting concentrations (~5 × 105 cfu/ml to ~9 × 109 
cfu/ml). Again, removal of bacteria from human serum was found to be strongly dependent on the initial con-
centration of bacterial cells present (Fig. 4b). Despite initial drops in viability, starting concentrations of K. pneu-
moniae cells above 7.76 × 106 cfu/ml were found to recover and persist in serum following a period of regrowth. 
In contrast, lower starting concentrations swiftly dropped below our limit of detection (<1 × 103 cfu/ml) and did 
not recover by 72 h. We used all the values for experimentally-determined reduction of K. pneumoniae in serum 
(Fig. 5a) to fit the K. pneumoniae growth parameters in our serum model. We assumed an initial condition for 
serum antimicrobials (I) from the best-fit parameters we obtained from parameter fitting the B. bacteriovorus 
reduction data. This modelling and experimentation guided us in selecting appropriate predator to prey starting 
concentrations for predation assays in human serum, reported below.
Predation of K. pneumoniae (KPC) in human serum. Having measured and modelled the interactions 
between serum prey and predators alone, and having quantified the dynamic responses that alter their pheno-
types in response to the serum surroundings; we then compared predation in serum versus that in buffer.
To investigate and model potentially important differences between predation in buffer and biological fluid, we 
repeated our buffer based assays in batches of human serum where factors other than predator-prey interaction 
could ameliorate bacterial numbers. Selection of initial predator to prey ratio for predation experiments in human 
serum was informed by the viability of K. pneumoniae KPC and B. bacteriovorus in serum reduction assays reported 
herein (Fig. 4a and b), and were chosen to be high enough that K. pneumoniae would not be cleared by serum alone, 
as in an established infection. As no accurate OD600 nm can be measured for small B. bacteriovorus cells, accurate 
predator concentrations cannot be determined at the time of inoculation. Therefore, an approximate but tight range 
of initial predator concentrations were achieved by establishing a highly reproducible protocol. Accurate initial pred-
ator numbers for such experiments are enumerated by post-experiment viable counting with results available after 
the experiment (these are plotted in Fig. 5 and subsequently used in the mathematical modelling).
An initial concentration of approximately 5 × 109 cfu/ml was selected for K. pneumoniae KPC prey on the 
basis that initial concentrations of this size were found to persist in serum for the duration of the assay (96 h) 
with only a minimal, early loss of viability (Fig. 4b). Therefore, significant reductions in prey viability, compared 
to controls, could be attributed to B. bacteriovorus, rather than solely any antimicrobial effect of the serum envi-
ronment. Conversely, an initial concentration of approximately 5 × 108 pfu/ml was chosen for B. bacteriovorus 
as starting concentrations of this size were found to steadily decrease in viability, in serum alone, with complete 
removal of predators occurring by 58 hours. This natural serum-related decrease in predators in the absence of 
prey allows us to attribute any rise in B. bacteriovorus, coupled with a decrease in K. pneumoniae, as an indicator 
of true predation causing predator replication. In addition the level of B. bacteriovorus used is similar to a topical 
dose applied to optical membranes of rabbit eyes, and reported as safe by Romanowski et al.37.
In contrast to assays performed in buffer, the dynamics of predation in serum were found to be more vari-
able and the synchronicity observed in buffer was lost. However, some common trends did emerge. Predation 
and reduction of K. pneumoniae was observed in all six independent experiments using two different batches of 
human serum, (Fig. 5a and b) as determined by a decrease in prey population coupled with an increase in pred-
ator numbers, but predation was invariably followed by regrowth of the prey population. However, the length of 
time before measurable predation occurred and the extent to which it occurred, was found to be variable between 
Figure 1. Schematic diagram of relationship between model variables based on biological mechanisms. The Ca/
HEPES buffer model has eight variables: free B. bacteriovorus predators (BDF), uninfected predation-susceptible 
K. pneumoniae prey (PS), uninfected predation-resistant K. pneumoniae prey (PR), prey with predator attached 
outside (PBDO), invaded prey with predator on the inside (PBDI), inactivated predator (BDI), nutritious 
waste (WN) and non-degradable waste (WM). The serum model has an additional two variables serum growth 
resources (R) and serum antimicrobials (I). Detailed description of the biological mechanisms can be found in 
the supplementary materials.
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the independent experiments, despite the small range of initial predator and prey concentrations, which ranged 
between 4.15 × 108−1.2 × 109 pfu/ml and 1.5–3.33 × 109 cfu/ml respectively. The length of delay before a measur-
able reduction in the prey population was seen correlated with the B. bacteriovorus viable count measured at eight 
hours. For example, in experiments 3 and 4, in which the least 8hr predator death occurred, (<1 Log10 reduction 
in predator concentration at eight hours), we see the earliest predation-effected decrease in prey concentration 
(between 24 and 32 hours). Conversely, in experiments 5 and 6, in which the most 8hr predator death occurs 
(>4 Log10 reduction in predator concentration at eight hours) we see the latest decrease in prey concentration 
(between 72 and 84 hours). This delay in predation, seen in all the independent experiments, is very different to 
the predation kinetics in buffer and important to appreciate when considering possible therapeutic applications.
The mathematical model (Fig. 6a) suggests that the delay in predation we observe in serum cannot be 
explained solely by the initial death of B. bacteriovorus, as predation then proceeds at a much slower rate than that 
measured and modelled in buffer. Nor can this decreased rate of predation be due to continuing clearance of the 
predator population by the antimicrobial component of the serum, as the model predicts serum antimicrobials 
Figure 2. Predation Experimentally Measured and Modelled in Ca/HEPES buffer. (a) Graphs show 
individual biological repeats- separate experiments (Expt) of the live bacterial counts from predation in buffer 
experiments, results from each individual biological experiment are represented by the same colour line on 
each graph. Changes in the population of both K. pneumoniae prey (Kp + HD100) and B. bacteriovorus HD100 
predator (HD100 + Kp) were enumerated periodically during the predation assay. As a control, prey suspended 
in Ca/HEPES was enumerated periodically in the absence of B. bacteriovorus HD100 predator (Kp alone). 
(b) Prey concentration (green line) initially shows a 6 log10 reduction by 6 hours (see inset) before regrowth 
overtakes predation effects. Predator concentration (orange line) grows in line with the prey death for the first 
six hours then reduces, in line with experimental results. Experimental results reproduced from A shown as a 
bar plot, the model simulation lies within the error bars of the experimental results. (c) Model simulation results 
showing prey with a predator attached (PBDO), prey with a predator inside (PBDI) and inactivated predators 
(BDI) over time. Attachment drops off after 5 hours due to prey becoming resistant.(d) Model simulation of 
waste accumulation over time. Non-degradable waste increases monotonically leading to prey resistance whilst 
nutritious waste initially increases but is then depleted as it is used by the growing predominently resistant prey. 
Parameter values and further model validation are detailed in supplementary material. The model gives a good 
fit to the experimental data.
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are exhausted within a few minutes of the start of the predation experiments (Fig. 6b). This has been confirmed 
experimentally, (Fig. 7a) and is discussed in detail later. Instead, the mathematical model suggests that a period 
of reduced attachment of predators to prey is also required to give the dynamics observed. Therefore, to better 
Figure 3. One-at-a-time sensitivity analysis of a ± 10% change in each parameter at three different time points. 
The variation in parameter sensitivity at different times reflects the different mechanisms dominating predator 
and prey interactions at those times. The sensitivity coefficient is scaled such that a value of ± 1 represents 
a ± 10% change in concentration as a result of a ± 10% change in parameter value. Parameter values detailed in 
Supplementary Table S2.
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understand the dynamics of predation in serum and to gain insights into potential causes for this delay, we per-
formed a microscopic study of predation in serum.
We used B. bacteriovorus HD100 expressing fluorescent mCherry protein (HD100 mCherry) in order to visu-
alize small predator cells microscopically in the visually complex medium of serum. Predation of K. pneumoniae 
prey by HD100 mCherry was verified (as this is genetically a different predator to HD100) in Fig. 8a. These results 
again show a drop in the concentration of the predator population at 8 hours (approximately 5 Log10 reduction) 
followed by recovery of B. bacteriovorus concentration and an associated delayed drop in the prey population at 
120 hours. Due to the altered genetic background of HD100 mCherry (chromosomal integration of the mCherry 
gene) and associated biological strain expressing the mCherry protein, the dynamics of predation may be differ-
ent to the wildtype, but the overall behaviour is the same (Fig. 8a). Therefore these HD100 mCherry results were 
not used for modelling purposes.
When predation events in serum were observed microscopically, we saw a rapid, early change in predator 
morphology. HD100 mCherry with typical vibroid morphology at 0 hours changed to a rounded morphology by 
two hours in serum with K. pneumoniae prey (Fig. 8b). Microscopic examples of fluorescent HD100 mCherry 
with altered morphologies are given in supplementary material Figure S3ab and the number of individual cells 
measured at each timepoint are provided in supplementary material Figure S4. The entire predator population 
began with a typical vibroid morphology (96.5% of all cells measured) but rapidly changed to a rounded morphol-
ogy by two hours in serum (1.94% of all cells measured retained a vibroid morphology at 2 hours). The proportion 
of the predator population with a vibroid morphology remained low up to 8 hours (3.67%) before beginning to 
slowly recover from 24 hours onwards (Fig. 8b). This trend coincided with an increase in viable counts in the 
predator population (Fig. 8a), presumably due to successful predation. This change in predator morphology is 
likely to have a large impact on predation events, including attachment to prey.
The model fits the experimental data well using a reduced early attachment rate (k1early) and introducing a 
delay parameter, δ, to determine how long that reduced attachment continues. As can be seen from the exper-
imental data (Fig. 5a,b), the length of the delay and the extent of the reduced attachment is variable between 
independent experiments in serum, and so studying the mean of all the experiments would be inappropriate 
as the smoothing effect would remove vital dynamics. For this reason, we began by fitting the parameters to the 
mean of experiments 1 and 2 only, which showed similar temporal dynamics in the experimental data, to obtain 
best-fit parameter values. We then set all the parameters to these best-fit values except k1early and δ which we fitted 
individually to each independent experiment. Figure 6a shows model simulations using best fit parameters for 
the model plotted using the mean of experiments 1 and 2. This serum model simulation (Figure 6a,i) shows, in 
line with experimental results, the drop in prey concentration at approximately 48 hours followed by regrowth 
to a stable concentration of approximately 2 × 108 cells/ml. B. bacteriovorus concentration in this simulation 
also compares well with the experimental data. Figure 6c shows the corresponding concentrations of predators 
Figure 4. (a) Reduction of B. bacteriovorus HD100 by whole human serum. A serially diluted preparation of 
B. bacteriovorus HD100 was inoculated into whole human serum and viability measured over a 72 h period. 
(b) Reduction of K. pneumoniae concentration by whole human serum. A serially diluted preparation of K. 
pneumoniae was inoculated into whole human serum and viability measured over a 72 h period by Miles and 
Misra. (c) Model simulations of B. bacteriovorus reduction in human serum for three different initial conditions. 
Solid line show simulation result whilst the circles show the experimental results (replicated from panel a). 
Parameter values are given in Supplementary Table S2, in the supplementary materials.
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attached to prey (PBDO), predators inside prey (PBDI) and inactivated predators (BDI) in the model simulation. 
These plots show that predation is halted until approximated 10 hours (as given by the delay parameter δ), then 
proceeds. Attachment rapidly declines after 56 hours as the prey become resistant to predation in the model (and 
apparently are predation resistant in our experimental data (Fig. 5a,b)). The model predicts a B. bacteriovorus 
replication time of 10 hours, which is longer than predation in buffer and is in line with estimates based on the 
rate of B. bacteriovorus increases in the experimental data from all biological repeats (Fig. 5).
The growth resources available to prey in the model have two sources, an initial serum component, which is 
rapidly depleted in the first hours of the simulation, and a predation-effected component which becomes signif-
icant in the system at approximately 50 hours as prey-lysis products start to accumulate, giving the high level of 
K. pneumoniae regrowth seen after 56 hours. Sensitivity analysis of the serum model (Supplementary material, 
Figure S5) at key points in the time course (early phase; lowest prey concentration stage and regrowth stage) high-
lights the multifactorial nature of the serum experimental system. Whilst the model is robust to changes in many 
parameters, it is most sensitive to changes in parameters relating to the death of B. bacteriovorus due to serum. 
In particular the prey concentration at 60 hours is by far the most sensitive to this, suggesting that changes in the 
ability of predator to resist the serum effects could have a large effect on the drop in prey numbers at this point.
To validate the best fit parameters we use in the model we also repeated the parameter estimation using two other 
groups of experiments (experiments 3 and 4; experiments 5 and 6). In both cases the only significant difference 
between the parameters chosen was the early attachment rate k1early (Supplementary material, Figure S6) as discussed 
above. Estimating the early attachment rate (k1early) and delay time (δ) individually showed us that the different 
behaviours observed experimentally can be substantially explained, and the model fitted to the all experimental 
data (Fig. 9) despite the complexity of the experimental data. The model suggests a small early attachment rate for all 
experiments with some variation in the extent of this and the time it takes to return to higher rates, hence free B. bac-
teriovorus get little protection from the serum at early timepoints and many are killed by serum antimicrobials and 
predator debris/predatory enzymes, with only a limited number of predators successfully entering prey at this stage.
Notably, a relatively small variation in the length of reduced attachment leads to much larger variation in the 
timing of the significant drop in prey numbers, this would support the view that the rounded predator cell majority 
are permanently prevented from entering prey, hence the long delay leads to reduced predator reproduction and 
it takes time to build up the progeny number to effectively then reduce K. pneumoniae numbers. A model with no 
early predator attachment to prey did not fit the data (not shown). The model does (Figure 6aii) predict an active but 
small predatory population at early timepoints (approximately 0.05% of the initial predator input at 2 hrs) and this 
correlated with a low percentage of vibroid B. bacteriovorus (1.94%) at the same timepoint in Fig. 8b).
Figure 5. Predation in two different batches of whole human serum. (a) Serum batch SLBN9196V. (b) Serum 
batch SLBN8826V. Graphs show individual biological repeats of the live bacterial counts from predation in serum 
experiments, results from each individual biological experiment (Expt) are represented by the same colour line on 
each graph. Changes in the population of both K. pneumoniae prey (Kp + HD100) and B. bacteriovorus HD100 
predator (HD100 + Kp) were enumerated periodically during the predation assay. As a control, prey suspended 
in serum was enumerated periodically in the absence of B. bacteriovorus HD100 predator (Kp alone). Despite 
illustrating some differences, similar patterns were seen across all 6 experimental repeats.
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In order to investigate the potential for serum derived components to bind to the surface of predator or prey 
and possibly halt predation, we separately exposed B. bacteriovorus and K. pneumoniae to whole human serum, 
prior to subsequent predation in Ca/HEPES buffer (Fig. 10). Pre-exposure of both predator and prey separately 
to whole human serum for two hours was found to have no subsequent delaying effect on predation once B. 
Figure 6. Model simulations of predation in human serum in comparison to experimental data, validating 
parameters estimated. (a) Model simulations with the best fit parameters (given in Supplementary Table S2) give a 
good fit to experimental data (mean of experimental repeats 1 and 2 from Fig. 5), with comparable dynamics. The 
drop in prey concentration due to predation and corresponding rise in predator numbers seen in the experimental 
data is replicated in the numerical simulation (b) The predators attached to prey (PBDO), predators inside prey i.e. 
bdelloplast (PBDI) and inactivated predators (BDI) are shown plotted against time. All three plots show a halting of 
predation for the first approximately 15 hours, then a continuing of the predatory cycle. By around 56 hours all the 
prey have become resistant. (c) The simulated serum antimicrobial concentrations showed that the antimicrobial 
activity of the serum is used up quickly (within the first 10 minutes of the simulation). Initial serum growth 
resources in the simulation are also quickly depleted, but an increase in growth resources is seen after 50 hours as 
lysis of bdelloplasts starts to release nutrients into the system.
Figure 7. (a) Classical pathway complement activity of human serum incubated in presence of predator 
and/or prey as measured by percent haemolysis of sensitised erythrocytes. Human serum was incubated at 
37 °C alone as a control (Serum alone) or in the presence of K. pneumoniae (Serum + Kp), in the presence of 
B. bacteriovorus HD100 (Serum + HD100) or in the presence of both K. pneumoniae and B. bacteriovorus 
HD100 (Serum + Kp + HD100). Serum was periodically sampled, filtered (0.2 µM) and diluted to 25% prior to 
measuring serum complement activity as determined by percent haemolysis of erythrocytes. CH50 serum values 
were calculated from these data and these are included in supplementary materials, Supplementary Table S1. (b) 
Enumeration of live bacterial populations incubated in human serum used for determining classical pathway 
complement activity. Predator and prey numbers in human serum were determined immediately prior to 
filtering (0.2 µM) and filtered aliquots were subsequently used for determining complement activity (panel a).
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bacteriovorus and K. pneumoniae were removed from serum and combined in Ca/HEPES buffer. Indeed, preda-
tion of K. pneumoniae (mean concentration at 0 hours 3.17 × 108 cfu/ml) by B. bacteriovorus (mean concentration 
at 0 hours 3.65 × 108 cfu/ml) following exposure to human serum proceeded in an almost identical fashion to that 
reported earlier in Ca/HEPES buffer (Fig. 10 vs Fig. 2a) with an approximate five Log10 drop in prey concentration 
by four hours incubation time. These results lead us to conclude that a binding of serum components, or early 
predator debris, to the cell surface of either K. pneumoniae or B. bacteriovorus, (that could inhibit attachment of 
active predators), is either highly reversible on washing in buffer, or unlikely to be the cause of the delay in preda-
tion we observe in our serum predation assays.
Changes in serum complement activity. It is not possible to measure experimentally (from a 
predator-prey mixture) all the antimicrobial components of serum, but one of the major antibacterial factors in 
serum that we could readily measure was complement through the classical pathway, using a haemolysis assay 
with predators and prey alone or in combination (Fig. 7a)30, 31. Additionally, changes in viability of the bacterial 
populations incubated in serum were enumerated over the 96 hour time period (Fig. 7b). Serum incubated in the 
presence of B. bacteriovorus alone, K. pneumoniae alone or in the presence of both predator and prey was depleted 
of classical complement pathway activity by 4 hours, the earliest time point measured. This experimental result 
fits with our mathematical model, which predicts the depletion of serum antimicrobial activity in less than 1 hour. 
This rapid loss of complement activity highlights one of the limitations of using a closed experimental system and 
should be considered when extrapolating results to some in vivo scenarios such as the circulatory system38, but is 
of relevance to isolated wound sites. It is possible that in a more refreshed system, where serum is replenished by 
bodily circulation that once prey numbers are reduced below a threshold level by B. bacteriovorus predation the 
antimicrobial activity of the serum, in combination with leukocytes, may clear the pathogen and the pathogen 
regrowth we observe in our closed model systems would not occur. We have established that we have a model that 
describes the additional complexity of predation in serum and accurately fits the extensive experimental results. 
Moreover, the modelling has guided experimentation to clarify the mechanisms involved in predator-prey-serum 
interactions.
Discussion
Antimicrobial resistance has emerged as a global health issue and has stimulated us to test and model how 
predatory B. bacteriovorus prey upon K. pneumoniae in this study. Multidrug resistant Gram-negative bacterial 
infections, especially those as a result of so-called ESKAPE pathogens39, including K. pneumoniae, are a real 
problem in developing and developed countries and in the healthcare setting13. Many of these infections include 
multidrug-resistant strains, at different bodily sites, designated currently ‘untreatable’ using conventional antibi-
otics40, 41. As a response, alternatives to antibiotics are being sought42, 43. The use of predatory bacteria, such as B. 
bacteriovorus, as “living antibiotics” is an attractive prospect but it is crucial to investigate Bdellovibrio-pathogen 
interactions and kinetics of predation in host-relevant environments, and to be able to predict the effects of pred-
ator doses, if they are to be used as a therapeutic agents. In light of this, we chose to model pathogen-predation in 
buffer compared to that in human serum.
Research to date modelling and quantifying the activity of predatory bacteria has focused mostly on labora-
tory strains of prey bacteria in ideal (buffer or growth media) conditions. Separate research has tested the effects 
Figure 8. (a) Predation in whole human serum by HD100 mCherry fluorescent predator. Changes in the 
population of both K. pneumoniae prey (Kp + HD100 mCherry) and B. bacteriovorus HD100 mCherry 
predator (HD100 mCherry + Kp) were enumerated periodically during the predation assay. As a control, K. 
pneumoniae prey suspended in serum was enumerated periodically in the absence of B. bacteriovorus HD100 
mCherry predator (Kp alone). (b) Microscopic analysis of B. bacteriovorus morphology in human serum 
with K. pneumoniae prey. MicrobeJ software was used to automatically detect mCherry tagged fluorescent B. 
bacteriovorus cells and measure the roundness (4 × area / (π × major axis2) of each individual cell at each time 
point. A roundness cut off of 0.65 was selected to distinguish between cells with typical vibroid morphology 
(roundness score < 0.65) and those with an abnormal round morphology (roundness score ≥ 0.65). Number 
of cells analysed ranged between 1026 and 109 cells. Exact sample sizes for each time point are given in 
Supplementary material, Figure S4.
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Figure 9. Model simulations of predation of K. pneumoniae by B. bacteriovorus in human serum, with varying 
levels delayed successful attachment, allows the model to fit each independent experiment (see Fig. 5 for 
experimental results).The delayed attachment parameter values for each experiment are k1early = [1.433 × 10−14; 
1.204 × 10−14; 3.999 × 10−12; 2.175 × 10−11; 6.597 × 10−16; 2.304 × 10−16] and δ = [11.03; 10.29; 10.43; 10.55; 
18.64; 17.49]. The remaining parameters which are fixed between experiments are given in Supplementary 
Table S2, in the supplementary material.
Figure 10. Predation in Ca/HEPES showing live bacterial numbers following pre-exposure of predator and 
prey to human serum. B. bacteriovorus HD100 and K. pneumoniae were exposed to human serum for two hours 
(t = −2 to 0 h). Predator and prey were then resuspended in Ca/HEPES and combined together in a predation 
assay and changes in the K. pneumoniae prey population enumerated periodically (Kp + HD100). As a control, 
K. pneumoniae prey previously exposed to human serum was resuspended in Ca/HEPES and enumerated 
periodically in the absence of B. bacteriovorus HD100 predator (Kp + Ca/HEPES). Arrows indicate the time at 
which bacteria were transferred from serum to buffer and subjected to respective treatment). B. bacteriovorus 
previously exposed to whole serum was added to K. pneumoniae to give a predator concentration at t = 0 h of 
approximately 5 × 108 pfu/ml.
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of pathogen treatments with predators in vivo without modelling. We need to improve our understanding of host 
relevant conditions under which B. bacteriovorus can prey on clinical, antibiotic-resistant strains of bacteria that 
cause untreatable infections. Although promising steps have been taken towards this with in vivo experimental 
studies of B. bacteriovorus as a therapeutic28, 44, including leukocyte interactions in Willis and co-workers, these 
experiments did not investigate underlying serum antibacterial mechanisms that may affect the dynamics of 
predation in a therapeutic setting. To address this, we set out to develop a model that captures the complexities 
of human serum and could therefore inform on predation dynamics in this setting and guide experimentation.
We have shown that B. bacteriovorus HD100 can effectively prey in both buffer and human serum on a clinical 
isolate of K. pneumoniae KPC, a major cause of carbapenem-resistant infections and problematic as a carrier 
status in patients45. We developed a mathematical model which fits the experimental data closely and we used this 
model to explore the underlying dynamics of predation. Through this interdisciplinary approach, we have shown 
that the interactions of this predator and pathogen in the human serum environment, and their responses to it are 
markedly different to that seen in buffer. These differences are indicative of the inherent problems of simplifying 
clinical processes to laboratory standards.
The mathematical model of the buffer-based predation experiments included terms relating to predation, prey 
growth and previously proposed “plastic resistance” phenotypes17, gave a good fit to the experimental data for 
both predator and prey concentrations over a 96 hour period and was validated with an independent data set. The 
parameter estimates for predator internalisation and time to predator-progeny release in buffer were within the 
range of observed times in E. coil35, and the estimated natural predator death rate was also in line with previous 
studies in buffer14. These factors lead us to believe we have a functional mechanistic model of B. bacteriovorus 
predation that includes the dominant mechanisms.
This paper shows for the first time that predation of a specific clinical pathogen by a predator in serum is 
markedly different to predation in buffer, and through the development of mathematical models directing further 
experimental validation, where experimentally tractable, we have addressed why this is the case. We show that, in 
the case of the predation in serum model, reduced initial predator attachment for a period up to 19 hours, com-
pared to the buffer model, makes it possible for the model to fit the serum-predation experimental results. Our 
model assumes that every attachment event results in successful predation, therefore the term “reduced attach-
ment” as used here, represents an increase in unsuccessful predator-prey attachment events that do not result in 
predation or simply less frequent attachment events occurring. To determine the cause of reduced early predator 
attachment, as suggested by the model, serum pre-incubation of predators or prey separately, prior to predation 
tests in buffer, were performed. These experiments suggested that the delay in predation observed was not as a 
result of direct binding of serum components to either the predator or prey cell surface, blocking attachment, as 
predation following exposure to human serum proceeded in an almost identical fashion to that reported earlier in 
Ca/HEPES buffer. Nor were the predators or prey irreversibly changed by the serum pre-treatment.
Serum is a complex mixture which is not amenable to microscopic work with small, unlabelled, predatory 
bacteria. However, the need to visualise predators during this delayed predation period led us to make additional 
microscopic observations of predation in serum using fluorescent HD100 mCherry predators. This showed that 
B. bacteriovorus rapidly changed from a typical vibroid morphology to a rounded morphology on initial contact 
with serum. At population level this altered morphology was temporary and predators were seen to have returned 
back to vibroid over the time course of the study. Vibroid morphology was associated with an increase in con-
centration of the predator population, presumably due to successful predation. Predator rounding may be more 
likely in a predator that has bound to and sensed prey but proving this experimentally is beyond the scope of this 
study. These results do suggest that preconditioning B. bacteriovorus to human serum is relevant for any future 
therapeutic use.
The detection of the predation delay in serum and directed experimentation, described above, emphasises the 
utility of our mathematical model, it provides insights into the population dynamics of predation that are difficult 
or impossible to determine experimentally. Predation events, such as attachment, are short lived and difficult to 
measure accurately, en masse, by direct microscopic observation, a task which becomes even more arduous in 
a complex granular medium such as serum. We therefore hypothesize that the delay in predation we observe in 
serum is a result of reduced successful attachment events arising from a change in predator morphology, which 
we observe experimentally. This morphology returns to vibroid over time, correlating with increasing B. bacterio-
vorus cell numbers after rare predation events have allowed predator replication. The observed delay in predation 
should be further explored experimentally, and studies investigating the transcriptional response of both predator 
and prey adapting to a serum environment are underway and may provide answers to this complex issue, but are 
beyond the scope of this work.
After accumulation of predators via rounds of replication there is a significant drop in the K. pneumoniae prey 
numbers but later there is a period of regrowth (Fig. 5). We make the assumption that prey cells accumulating 
in a serum-based population are becoming resistant to predation following initial prey bursting and exit in their 
neighbourhood. We postulate that this resistance is a plastic phenotypic resistance, as this has been reported pre-
viously for the predation of another gammaproteobacterium, Erwinia carotovora in buffer17. It should be stressed 
that this plastic resistance is believed to transient in nature rather than due to genetic mutation of the prey. 
Shemesh and Jurkevitch hypothesised that this phenotypic resistance may be due to modification they describe as 
“hardening of the prey cell wall” resulting from the release of low levels of lytic enzymes by predators during inef-
fective prey cell encounters. In our model, the development of prey phenotypic resistance in serum is dependent 
upon the amount of prey cell lysis resulting from predation. Lysed prey will release “waste”:- including a mixture 
of both intracellular prey enzymes and predator lytic enzymes, produced to effect bdelloplast exit. These free lytic 
enzymes may act on neighbouring cells, possibly resulting in the “hardening effect” described, or there may be 
other “anti-predation” modifications which await characterisation. This explanation would support the work of 
Shemesh and Jurkevitch, that predatory enzymes may play an indirect role in producing a transiently resistant 
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prey population17. Alternatively, this “predation-waste”, containing the remnants of prey cell membranes and 
walls left over from lysis46, may act as a physical barrier to attachment. We note, however, that the formulation 
of the model allows flexibility such that the model is not restricted to a particular underlying biological mecha-
nism(s) for this prey regrowth after predation. In a replenished circulatory system, in vivo, rather than the batch 
system we tested, we would not expect such waste accumulation and so such a “resistant” prey response may not 
be seen in privileged or minimally perfused body sites. The zebrafish infection study of Willis et al.28 may be a 
relevant example.
Predator-prey-serum interaction kinetics are important if B. bacteriovorus are ever to be used as topical (e.g. 
on tracheotomies), ingested (to attempt gut clearance for patients who are carriers), applied to wounds (surgically 
or environmentally caused) or inhaled (for lung infection) therapies for human Klebsiella infections. Recently 
Shatzkes et al.44 have highlighted the potential of one of these approaches, showing that repeated intranasal 
administration of. B. bacteriovorus 109 J can reduce the bacterial burden of K. pneumoniae in rat lungs. Their 
study was able to measure prey, but not predator, viability over a 24 hour period reporting a reduction of K. pneu-
moniae prey in the majority of animals.
The extended live predator and prey count data in our study emphasise the importance of building upon such 
studies44 to understand the dynamics of predation beyond any initial reduction in the prey population. The prey 
regrowth we observe in buffer and serum, presumably due to plastic resistance, could impede convalescence 
after B. bacteriovorus treatment and is important to address, hence our inclusion of a resistance mechanism 
in the model. Whilst the potential to treat an initial K. pneumoniae infection with B. bacteriovorus has been 
established44, preventing pathogen regrowth is just as crucial and needs further research. Recently, Willis et al.28 
demonstrated for the first time that injected B. bacteriovorus can be used to cure an otherwise lethal bacterial 
infection in living animals. They found that the synergistic action of the innate immune system with the predatory 
bacteria were responsible for reduced pathogen numbers and increased survival in zebrafish larvae. Our serum 
predation modelling is an important precursor to a further study including leukocytes and as a “3Rs” strategy to 
reduce the use of unnecessary animals in medical research.
The approach we take here, combining modelling with experimental verification of growth response by a clin-
ical pathogen in human serum, shows that pathogen regrowth after predation can be modelled. This encourages 
future quantitative research in more complex bodily settings, such as wounds, with innate immune cells acting 
also. This approach may aid dosing and viable predator-persistence considerations for more systemic studies such 
as the bloodstream injections of predators recently published by Shatzkes et al.38.
Our work here and future models will assist the design of a treatment regime aimed at preventing such 
regrowth, such as exploring whether multiple doses of B. bacteriovorus could synergise with the immune system 
to clear an infection.
In summary, in this work we have shown for the first time that B. bacteriovorus can effectively prey on the 
antibiotic-resistant, human-pathogen K. pneumoniae KPC in human serum, as well as buffer. There can be later 
regrowth of the pathogen, post-predation, which needs to be researched further. We have shown that the dynam-
ics of predation in human serum are complex and differ significantly from the comparatively simple dynam-
ics of predation in buffer. The synergy of mathematical modelling and experimental science has provided new 
theories for the mechanisms behind these differences. These insights guide future experimentation to mitigate 
delayed predation in serum and prey regrowth, for efficient therapeutic administration of B. bacteriovorus in 
serum-rich settings, such as infected wounds. Also a study of how, or if, predators and prey secrete compounds 
that change serum composition will be valuable. Future strategies to produce the most active predator doses may 
come from pre-adaptation of predators in serum prior to administration, or the development of serum resistant 
B. bacteriovorus strains through forced evolution. This study has highlighted the importance of using realistic, 
bodily-derived media, extended time-course studies and mathematical modelling as we take steps towards vali-
dating predatory bacteria as living antibiotics.
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